Kemp, J.A.; Mendonça, M.; Chrispim, P.; Ribeiro, M.; Britto, I.; Coutinho-Wolino, K.S.; Ribeiro-Alves, M.; Nakao, L.S.; Kussi, F.; Coelho, E.B.;
et al. Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis. Toxins 2025, 17, 369.
https://doi.org/10.3390/toxins17080369
AMA Style
Kemp JA, Mendonça M, Chrispim P, Ribeiro M, Britto I, Coutinho-Wolino KS, Ribeiro-Alves M, Nakao LS, Kussi F, Coelho EB,
et al. Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis. Toxins. 2025; 17(8):369.
https://doi.org/10.3390/toxins17080369
Chicago/Turabian Style
Kemp, Julie Ann, Marianna Mendonça, Paloma Chrispim, Marcia Ribeiro, Isadora Britto, Karen S. Coutinho-Wolino, Marcelo Ribeiro-Alves, Lia S. Nakao, Fernanda Kussi, Eduardo B. Coelho,
and et al. 2025. "Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis" Toxins 17, no. 8: 369.
https://doi.org/10.3390/toxins17080369
APA Style
Kemp, J. A., Mendonça, M., Chrispim, P., Ribeiro, M., Britto, I., Coutinho-Wolino, K. S., Ribeiro-Alves, M., Nakao, L. S., Kussi, F., Coelho, E. B., Berretta, A. A., Mafra, D., & Cardozo, L.
(2025). Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis. Toxins, 17(8), 369.
https://doi.org/10.3390/toxins17080369
